Kymanox

Kymanox, founded in 2004, is a life science solutions partner that aims to advance life science innovation through insightful solutions and collaboration. The company accelerates the design and commercialization of modern medicines for its customers using integrated engineering, scientific, compliance, and project management solutions that are insightful, collaborative, and comprehensive. Its slogan, "Your Life Science Solutions Partner - Bio | Pharma | Device | Combo... because patients deserve better," reflects its commitment to improving patient outcomes.

With a focus on bringing better life science products to the market and keeping them there, Kymanox has established itself as a key player in the industry. It serves clients from Fortune 100 companies to virtual start-up companies globally, showcasing its ability to cater to diverse needs within the life science sector. Headquartered in Research Triangle Park, NC, Kymanox has expanded its presence to include US offices in Boston and Philadelphia, as well as international offices in Germany, Switzerland, and Israel, demonstrating its commitment to global outreach.

The company's dedication to its mission is further exemplified by its last recorded investment, a Debt Financing investment at 23 August 2021, which was secured from Abacus Finance Group. This investment not only underscores Kymanox's financial stability and growth potential but also highlights its appeal to reputable investors within the industry.